Wataru Ishida

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Cell Cycle Arrest

Epithelial Mesenchymal Transition

Histone Deacetylase

Reactive Oxygen Species

Top Venues

The Journal of bone and joint surgery. American volume

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

Johns Hopkins Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins Hospital Jun 01 2020

United States

Resident :: Neurosurgery

Johns Hopkins University

United States

Postdoctoral fellow :: Department of Neurosurgery

Columbia University Medical Center Jul 01 2016 - Sep 30 2017

United States

Postdoctoral Fellow :: Department of Neurosurgery

Tokyo Metropolitan Neurological Hospital Apr 01 2014

Japan

Neurosurgical Intern :: Department of Neurosurgery

Toranomon Byoin Apr 01 2012 - Mar 31 2014

Japan

Neurosurgical intern

Publications

Wataru Ishida, Alexander Perdomo-Pantoja, Benjamin D Elder, John Locke, Christina Holmes, Timothy F Witham, Sheng-Fu Larry Lo
Effects of Intraoperative Intrawound Antibiotic Administration on Spinal Fusion: A Comparison of Vancomycin and Tobramycin in a Rat Model. The Journal of bone and joint surgery. American volume 101 (19) (2020)
Sakibul Huq, Joshua Casaos, Riccardo Serra, Michael Peters, Yuanxuan Xia, Andy S Ding, Jeff Ehresman, Jayanidhi N Kedda, Manuel Morales, Noah L Gorelick, Tianna Zhao, Wataru Ishida, Alexander Perdomo-Pantoja, Arba Cecia, Chenchen Ji, Ian Suk, David Sidransky, Mariana Brait, Henry Brem, Nicolas Skuli, Betty Tyler
Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma. Molecular cancer therapeutics 19 (9) (2020)
Yiru Zhang, Chiaki Tsuge Ishida, Wataru Ishida, Sheng-Fu L Lo, Junfei Zhao, Chang Shu, Elena Bianchetti, Giulio Kleiner, Maria J Sanchez-Quintero, Catarina M Quinzii, Mike-Andrew Westhoff, Georg Karpel-Massler, Peter Canoll, Markus D Siegelin
Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (16) (2018)